Close Menu

NEW YORK – Invitae today announced a $50 million deal to acquire Jungla, an artificial intelligence-driven biotech firm that it believes will enhance its variant interpretation capabilities.

Jungla has developed the cloud-based Functional Modeling Platform, which uses machine learning to integrate functional, structural, and computational data and create predictive models that can be used to interpret the clinical significance of genomic variants. Invitae sees this technology as complementary to its own variant classification and interpretation method, called Sherloc.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.